Trial intelligence / Profile preview

Levofloxacin bronchial and lung tissue penetration study

ChiCTR2000029096Phase 4Completed

Sponsor
Huashan Hospital
Start
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of levofloxacin in pulmonary infection (2 arms), sponsored by Huashan Hospital. Primary endpoints: Levofloxacin concentration in sputum, Levofloxacin concentration in bronchoalveolar lavage fluid and 3 more. Started Oct 2006; status: completed.

02

Drugs

levofloxacin
03

Conditions

pulmonary infection

Beyond the preview

Go deeper on ChiCTR2000029096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000029096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call